Key details Disabling condition: Duchenne muscular dystrophy (DMD) is a severe, genetic condition that causes progressive muscle weakness due to the absence of dystrophin, a protein essential for maintaining muscle integrity. Increasing scientific interest in whether...
Key details Current treatment limitations: While ischaemic strokes – which account for nearly 90% of all strokes – are currently treated with clot removal and supportive rehabilitation, there remains a significant unmet need for therapies that directly address...
Key details New trial approval: The South Korean Ministry of Food and Drug Safety has approved a Phase 2a trial for a new umbilical cord stem cell therapy to treat Charcot-Marie-Tooth disease (CMT), one of the most commonly inherited nerve diseases.[1] Early clinical...
Key details Understanding Lesch-Nyhan syndrome: This rare, recessive condition linked to the X chromosome primarily affects boys, and is characterised by a deficiency of the HPRT enzyme, leading to severe motor dysfunction, uric acid overproduction, and compulsive...
A six-year-old girl named Zara has become the first child in Australia to receive an infusion of her own stored cord blood as treatment for cerebral palsy outside of a clinical trial. Experts hope that this milestone will pave the way towards broader availability,...
Researchers are investigating a novel placenta-derived stem cell therapy for multiple sclerosis, a currently incurable degenerative neurological condition. A recent phase 1 clinical trial, with findings published in Scientific Reports, assessed the safety and...
Stem Cell Therapy Potential for Duchenne Muscular Dystrophy
Stem Cell Therapy Shows Promise for Ageing Frailty
Clinical Trial Explores Placental Stem Cell Gel for Radiotherapy Skin Damage
